Ardsley Advisory Partners LP Has $4.97 Million Stock Position in Tenet Healthcare Corporation $THC

Ardsley Advisory Partners LP lowered its holdings in shares of Tenet Healthcare Corporation (NYSE:THC) by 28.6% in the 4th quarter, HoldingsChannel reports. The firm owned 25,000 shares of the company’s stock after selling 10,000 shares during the period. Ardsley Advisory Partners LP’s holdings in Tenet Healthcare were worth $4,968,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in THC. Triumph Capital Management acquired a new stake in Tenet Healthcare in the third quarter valued at approximately $25,000. Activest Wealth Management bought a new stake in Tenet Healthcare during the fourth quarter worth $26,000. Elyxium Wealth LLC bought a new stake in Tenet Healthcare during the fourth quarter worth $29,000. Canada Pension Plan Investment Board bought a new stake in Tenet Healthcare during the second quarter worth $35,000. Finally, Meeder Asset Management Inc. lifted its holdings in Tenet Healthcare by 146.2% during the fourth quarter. Meeder Asset Management Inc. now owns 192 shares of the company’s stock worth $38,000 after acquiring an additional 114 shares during the period. Institutional investors and hedge funds own 95.44% of the company’s stock.

Analyst Ratings Changes

Several brokerages have issued reports on THC. Barclays lowered their target price on Tenet Healthcare from $257.00 to $238.00 and set an “overweight” rating on the stock in a research note on Tuesday, May 5th. Stephens reduced their target price on Tenet Healthcare from $275.00 to $260.00 and set an “overweight” rating for the company in a research report on Monday, May 4th. Morgan Stanley set a $254.00 target price on Tenet Healthcare in a research report on Friday, May 1st. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of Tenet Healthcare in a research note on Wednesday, March 4th. Finally, Wells Fargo & Company dropped their price target on Tenet Healthcare from $265.00 to $213.00 and set an “overweight” rating for the company in a research note on Friday, May 1st. Eighteen investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat, Tenet Healthcare has a consensus rating of “Moderate Buy” and a consensus price target of $244.16.

Insider Activity at Tenet Healthcare

In related news, Director J Robert Kerrey sold 5,638 shares of the company’s stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $174.52, for a total value of $983,943.76. Following the sale, the director owned 16,804 shares in the company, valued at $2,932,634.08. This represents a 25.12% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Nadja West sold 3,000 shares of the company’s stock in a transaction that occurred on Wednesday, May 27th. The stock was sold at an average price of $177.35, for a total value of $532,050.00. Following the completion of the sale, the director owned 24,805 shares in the company, valued at $4,399,166.75. The trade was a 10.79% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 0.97% of the company’s stock.

Tenet Healthcare Trading Down 2.7%

THC opened at $178.63 on Thursday. Tenet Healthcare Corporation has a one year low of $146.60 and a one year high of $247.21. The business has a 50 day simple moving average of $183.44 and a two-hundred day simple moving average of $199.04. The company has a debt-to-equity ratio of 1.96, a current ratio of 1.36 and a quick ratio of 1.30. The firm has a market capitalization of $15.39 billion, a price-to-earnings ratio of 9.29, a PEG ratio of 1.51 and a beta of 1.28.

Tenet Healthcare (NYSE:THC) last posted its earnings results on Thursday, April 30th. The company reported $4.82 earnings per share for the quarter, topping analysts’ consensus estimates of $4.21 by $0.61. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.The firm had revenue of $5.37 billion for the quarter, compared to the consensus estimate of $5.39 billion. During the same quarter in the prior year, the business earned $4.36 EPS. The business’s revenue for the quarter was up 2.6% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. Analysts predict that Tenet Healthcare Corporation will post 17.61 EPS for the current year.

Tenet Healthcare Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.